Maya L. Nadimpalli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maya L. Nadimpalli has a total of 285 co-authors. Here are the top co-authors by number of shared publications:
Shira Doron
7 shared publicationsSamson Alemu Argaw
6 shared publicationsNanguneri Nirmala
Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA
5 shared publicationsSarah Blackmon
5 shared publicationsSweta Balaji
Department of Quantitative Theory and Methods, Emory University, Atlanta, Georgia, USA
5 shared publicationsAgathe de Lauzanne
Epidemiology and Public Health Unit Institut Pasteur in Cambodia Phnom Penh Cambodia
4 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by Springer Nature in Research Square
Hidden antibiotic exposures: A scoping review of residues detected in humans without recent, intentional use
Background Antibiotic residues are commonly reported in food, water, and soil. Despite concerns that chronic, low-dose exposures could perturb the human gut microbiome and select for antimicrobial resistance, it remains unclear how prevalent these exposures are in the general population. The goal of this scoping review was to compile and summarize existing evidence for the detection of antibiotic residues in human samples (e.g., blood, breast milk, urine, stool) from individuals without known, recent antibiotic use. Methods We systematically searched PubMed, Embase, and Scopus (1990 through October 2025) for studies reporting antibiotic detection in humans with no recent antibiotic use, hereafter termed “inadvertent antibiotic exposure” (IAE). All methods for ascertaining recent antibiotic use (e.g. medical record review, self-report) were eligible. No minimum antibiotic abstention period was required for inclusion. Any age, sex, country, or human specimen type was eligible. Literature reviews, case-series, and case control study designs were excluded. Abstract screening, full-text screening, and data extraction were performed in duplicate. Results Thirty-two studies including 11,499 participants from 10 predominantly low- and middle-income countries met inclusion criteria. Most assessed antibiotic activity in urine (n = 24), though stool, breast milk, blood, and fat were also analyzed (< 5 studies each). The average minimum antibiotic abstention time was 3.1 months. At the person level, half of tested participants (standard deviation (SD): 30%) were positive for at least one antibiotic residue or metabolite. Norfloxacin, ofloxacin, and ciprofloxacin were each identified in one fifth of participants. Reported maximum urinary concentrations of ciprofloxacin were comparable to therapeutic levels. We noted substantial gaps that limit the generalizability of current evidence, including no published studies from Europe and North America, reliance on self-report for ascertaining recent antibiotic exposure, and heterogeneity in analytical methods and outcome reporting. Discussion Overall, this review finds evidence of a broad range of antibiotic residues - including agents classified as critically important for human health - in up to 50% of individuals with no recent, self-reported antibiotic exposure. Our results indicate that IAE is common in many low and middle-income countries, although it remains poorly characterized in other settings. Our findings underscore the relevance of investigating the sources and consequences of IAE, including its potential effects on the microbiome and global antimicrobial resistance.
- 28 September 2026
- Published by Springer Nature in Research Square
Open AccessHidden antibiotic exposures: A scoping review of residues detected in humans without recent, intentional use
Background Antibiotic residues are commonly reported in food, water, and soil. Despite concerns that chronic, low-dose exposures could perturb the human gut microbiome and select for antimicrobial resistance, it remains unclear how prevalent these exposures are in the general population. The goal of this scoping review was to compile and summarize existing evidence for the detection of antibiotic residues in human samples (e.g., blood, breast milk, urine, stool) from individuals without known, recent antibiotic use. Methods We systematically searched PubMed, Embase, and Scopus (1990 through October 2025) for studies reporting antibiotic detection in humans with no recent antibiotic use, hereafter termed “inadvertent antibiotic exposure” (IAE). All methods for ascertaining recent antibiotic use (e.g. medical record review, self-report) were eligible. No minimum antibiotic abstention period was required for inclusion. Any age, sex, country, or human specimen type was eligible. Literature reviews, case-series, and case control study designs were excluded. Abstract screening, full-text screening, and data extraction were performed in duplicate. Results Thirty-two studies including 11,499 participants from 10 predominantly low- and middle-income countries met inclusion criteria. Most assessed antibiotic activity in urine (n = 24), though stool, breast milk, blood, and fat were also analyzed (< 5 studies each). The average minimum antibiotic abstention time was 3.1 months. At the person level, half of tested participants (standard deviation (SD): 30%) were positive for at least one antibiotic residue or metabolite. Norfloxacin, ofloxacin, and ciprofloxacin were each identified in one fifth of participants. Reported maximum urinary concentrations of ciprofloxacin were comparable to therapeutic levels. We noted substantial gaps that limit the generalizability of current evidence, including no published studies from Europe and North America, reliance on self-report for ascertaining recent antibiotic exposure, and heterogeneity in analytical methods and outcome reporting. Discussion Overall, this review finds evidence of a broad range of antibiotic residues - including agents classified as critically important for human health - in up to 50% of individuals with no recent, self-reported antibiotic exposure. Our results indicate that IAE is common in many low and middle-income countries, although it remains poorly characterized in other settings. Our findings underscore the relevance of investigating the sources and consequences of IAE, including its potential effects on the microbiome and global antimicrobial resistance.
- Open Access
- 25 April 2026
- Published by Elsevier in One Health
- Vol. 22, 101429
Strain-level analyses of public sequencing data to characterize Escherichia coli strain sharing between children and chickens in Mozambique
- 25 April 2026
- Published by Elsevier in One Health
- Vol. 22, 101429
Open AccessStrain-level analyses of public sequencing data to characterize Escherichia coli strain sharing between children and chickens in Mozambique
- Open Access
- 19 November 2025
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 91 (11) , e0168425
Using wastewater surveillance to investigate community-level differences in antibacterial resistance in a major urban center, USA
Wastewater surveillance could be a low-cost strategy for assessing patterns of antibiotic resistance across urban populations. We quantified fluoroquinolone-resistant (FQ-R) Enterobacterales, third-generation cephalosporin-resistant (3GC-R) Enterobacterales, carbapenem-resistant Enterobacterales, and the bla CTX-M -group 1 and bla KPC genes in influent wastewater from 12 diverse sewersheds across metro Atlanta over two seasons; examined associations between culture- and digital PCR-based outcomes; and investigated relationships between sewersheds’ sociodemographic characteristics and concentrations of antibiotic-resistant bacteria in wastewater. FQ-R Enterobacterales, 3GC-R Escherichia coli , and 3GC-R Klebsiella , Enterobacter , or Citrobacter spp. (KEC) were detected in 79%–94% of samples ( n = 34), with concentrations differing among sewersheds. Carbapenem-resistant E. coli and KEC were not reliably detected. The bla CTX-M -group 1 gene was detected in every sample, and we detected trends toward an association with 3GC-R E. coli and KEC, suggesting potential utility of this gene as a monitoring target. The bla KPC gene was detected in every sample despite carbapenem-resistant E. coli and KEC not being reliably detected, suggesting it is not an appropriate indicator for these bacteria. After accounting for season, repeated measures, and potential healthcare inputs, we found that sewersheds with higher proportions of crowded households, Hispanic, non-Hispanic Asian, and individuals speaking a language other than English at home had higher flow-normalized concentrations of FQ-R Enterobacterales, 3GC-R E. coli and/or KEC in their wastewater. Given the potential for confounding, comparisons with human data are needed to determine how well sociodemographic patterns observed through wastewater mirror trends in the population. IMPORTANCE: Wastewater surveillance is a popular tool for the monitoring of health-related targets. Previous studies have demonstrated increases in antibiotic resistance among wastewater-derived fecal pathogens that match temporal trends in geographically-matched patient populations, indicating utility for assessing population-level patterns. Few studies have studied wastewater to examine antibiotic resistance patterns within a city or to identify sociodemographic characteristics associated with higher concentrations. We tested municipal wastewater from 12 sewersheds across metro Atlanta across two seasons. We identified significant differences in antibiotic-resistant bacterial concentrations across sewersheds, and after accounting for season, repeated sampling, and potential inputs from healthcare facilities, we found these differences were associated with community characteristics like living conditions and language. Overall, given that clinical surveillance is unlikely to be representative of the US population due to unequal healthcare access, wastewater surveillance merits consideration as a novel approach for antibiotic resistance surveillance.
- 19 November 2025
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 91 (11) , e0168425
Open AccessUsing wastewater surveillance to investigate community-level differences in antibacterial resistance in a major urban center, USA
Wastewater surveillance could be a low-cost strategy for assessing patterns of antibiotic resistance across urban populations. We quantified fluoroquinolone-resistant (FQ-R) Enterobacterales, third-generation cephalosporin-resistant (3GC-R) Enterobacterales, carbapenem-resistant Enterobacterales, and the bla CTX-M -group 1 and bla KPC genes in influent wastewater from 12 diverse sewersheds across metro Atlanta over two seasons; examined associations between culture- and digital PCR-based outcomes; and investigated relationships between sewersheds’ sociodemographic characteristics and concentrations of antibiotic-resistant bacteria in wastewater. FQ-R Enterobacterales, 3GC-R Escherichia coli , and 3GC-R Klebsiella , Enterobacter , or Citrobacter spp. (KEC) were detected in 79%–94% of samples ( n = 34), with concentrations differing among sewersheds. Carbapenem-resistant E. coli and KEC were not reliably detected. The bla CTX-M -group 1 gene was detected in every sample, and we detected trends toward an association with 3GC-R E. coli and KEC, suggesting potential utility of this gene as a monitoring target. The bla KPC gene was detected in every sample despite carbapenem-resistant E. coli and KEC not being reliably detected, suggesting it is not an appropriate indicator for these bacteria. After accounting for season, repeated measures, and potential healthcare inputs, we found that sewersheds with higher proportions of crowded households, Hispanic, non-Hispanic Asian, and individuals speaking a language other than English at home had higher flow-normalized concentrations of FQ-R Enterobacterales, 3GC-R E. coli and/or KEC in their wastewater. Given the potential for confounding, comparisons with human data are needed to determine how well sociodemographic patterns observed through wastewater mirror trends in the population. IMPORTANCE: Wastewater surveillance is a popular tool for the monitoring of health-related targets. Previous studies have demonstrated increases in antibiotic resistance among wastewater-derived fecal pathogens that match temporal trends in geographically-matched patient populations, indicating utility for assessing population-level patterns. Few studies have studied wastewater to examine antibiotic resistance patterns within a city or to identify sociodemographic characteristics associated with higher concentrations. We tested municipal wastewater from 12 sewersheds across metro Atlanta across two seasons. We identified significant differences in antibiotic-resistant bacterial concentrations across sewersheds, and after accounting for season, repeated sampling, and potential inputs from healthcare facilities, we found these differences were associated with community characteristics like living conditions and language. Overall, given that clinical surveillance is unlikely to be representative of the US population due to unequal healthcare access, wastewater surveillance merits consideration as a novel approach for antibiotic resistance surveillance.
- 24 September 2025
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 80 (12) , 3248-3256
Effects of commonly used antibiotics on children’s developing gut microbiomes and resistomes in peri-urban Lima, Peru
Background: The effects of antibiotic use on children’s gut microbiomes and resistomes are not well characterized in middle-income countries, where antibiotic consumption is exceptionally common. Objectives: We characterized the effects of antibiotics commonly used by Peruvian children (i.e. amoxicillin, azithromycin, cefalexin, trimethoprim/sulfamethoxazole) on the α-diversity, β-diversity and abundance of gut genera and antibiotic resistance genes (ARGs) from 3 to 16 months. Methods: This study included 54 children from a prospective cohort of enteric infections in peri-urban Lima, 2016–19. Stools collected at 3, 6, 7, 9, 12 and 16 months underwent DNA extraction and short-read metagenomic sequencing. We profiled the taxonomy of stool metagenomes and assessed ARG abundance by aligning reads to the ResFinder database. We used daily surveillance data (40 662 observations) to tabulate the number of antibiotic courses consumed in the 30 days prior to stool sampling. Using linear mixed models, we examined associations of recent antibiotic use with richness, diversity and abundance of gut genera and ARGs over time. Results: Each additional recent antibiotic course decreased Bifidobacterium and Dialister abundance and increased Veillonella abundance, although gut richness and diversity were not affected. Recent use of amoxicillin, azithromycin, cefalexin or trimethoprim/sulfamethoxazole, specifically, did not impact gut microbiome measures. Amoxicillin, azithromycin and trimethoprim/sulfamethoxazole significantly enriched multiple ARGs and amoxicillin use significantly increased total ARGs. Conclusions: Common antibiotics like amoxicillin and azithromycin appear to be key drivers of the paediatric gut resistome. Resistome perturbations appeared to be stronger, or persist for longer, than gut microbiome effects in this middle-income country setting.
- 24 September 2025
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 80 (12) , 3248-3256
Effects of commonly used antibiotics on children’s developing gut microbiomes and resistomes in peri-urban Lima, Peru
Background: The effects of antibiotic use on children’s gut microbiomes and resistomes are not well characterized in middle-income countries, where antibiotic consumption is exceptionally common. Objectives: We characterized the effects of antibiotics commonly used by Peruvian children (i.e. amoxicillin, azithromycin, cefalexin, trimethoprim/sulfamethoxazole) on the α-diversity, β-diversity and abundance of gut genera and antibiotic resistance genes (ARGs) from 3 to 16 months. Methods: This study included 54 children from a prospective cohort of enteric infections in peri-urban Lima, 2016–19. Stools collected at 3, 6, 7, 9, 12 and 16 months underwent DNA extraction and short-read metagenomic sequencing. We profiled the taxonomy of stool metagenomes and assessed ARG abundance by aligning reads to the ResFinder database. We used daily surveillance data (40 662 observations) to tabulate the number of antibiotic courses consumed in the 30 days prior to stool sampling. Using linear mixed models, we examined associations of recent antibiotic use with richness, diversity and abundance of gut genera and ARGs over time. Results: Each additional recent antibiotic course decreased Bifidobacterium and Dialister abundance and increased Veillonella abundance, although gut richness and diversity were not affected. Recent use of amoxicillin, azithromycin, cefalexin or trimethoprim/sulfamethoxazole, specifically, did not impact gut microbiome measures. Amoxicillin, azithromycin and trimethoprim/sulfamethoxazole significantly enriched multiple ARGs and amoxicillin use significantly increased total ARGs. Conclusions: Common antibiotics like amoxicillin and azithromycin appear to be key drivers of the paediatric gut resistome. Resistome perturbations appeared to be stronger, or persist for longer, than gut microbiome effects in this middle-income country setting.
- Open Access
- 18 September 2025
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 5 (1) , e232
Race and ethnicity and the risk of community-acquired third-generation cephalosporin-resistant uropathogens: a systematic review and meta-analysis – CORRIGENDUM
- 18 September 2025
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 5 (1) , e232
Open AccessRace and ethnicity and the risk of community-acquired third-generation cephalosporin-resistant uropathogens: a systematic review and meta-analysis – CORRIGENDUM
- Open Access
- 7 August 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (8) , e017404
Race, ethnicity and risk for colonisation and infection with key bacterial pathogens: a scoping review
Background: Racial and ethnic disparities in infectious disease burden have been reported in the USA and globally, most recently during the COVID-19 pandemic. It remains unclear whether such disparities also exist for priority bacterial pathogens that are increasingly antimicrobial-resistant. We conducted a scoping review to summarise published studies that report on colonisation or community-acquired infection with pathogens among different races and ethnicities. Methods: We conducted an electronic literature search of MEDLINE, Daily, Global Health, Embase, Cochrane Central and Web of Science from inception to March 2024 for eligible observational studies. Abstracts and full-text publications were screened in duplicate for studies that reported data for race or ethnicity for at least one of the pathogens of interest. Results: 62 observational studies in 68 publications met our inclusion criteria. Studies reported results for Staphylococcus aureus (n=61), Escherichia coli (n=9), Pseudomonas aeruginosa (n=2), Enterobacterales (n=1), Enterococcus faecium (n=1) and Klebsiella pneumoniae (n=1) and were conducted in the USA (n=48), Israel (n=6), New Zealand (n=4), Australia (n=3) and Brazil (n=1). US studies most often examined Black and Hispanic minority groups and regularly reported a higher risk of these pathogens in Black persons and mixed results for Hispanic persons. Ethnic minority groups were often reported to be at a higher risk in other countries. Conclusions: Sufficient evidence was identified to justify systematic reviews and meta-analyses evaluating the relationship between race, ethnicity and community-acquired S. aureus and E. coli, although data were rare for other pathogens. We recommend that future studies clarify whether race and ethnicity data are self-reported, collect race and ethnicity data in conjunction with the social determinants of health and make a concerted effort to include non-English speakers and Indigenous populations from the Americas, when possible.
- 7 August 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (8) , e017404
Open AccessRace, ethnicity and risk for colonisation and infection with key bacterial pathogens: a scoping review
Background: Racial and ethnic disparities in infectious disease burden have been reported in the USA and globally, most recently during the COVID-19 pandemic. It remains unclear whether such disparities also exist for priority bacterial pathogens that are increasingly antimicrobial-resistant. We conducted a scoping review to summarise published studies that report on colonisation or community-acquired infection with pathogens among different races and ethnicities. Methods: We conducted an electronic literature search of MEDLINE, Daily, Global Health, Embase, Cochrane Central and Web of Science from inception to March 2024 for eligible observational studies. Abstracts and full-text publications were screened in duplicate for studies that reported data for race or ethnicity for at least one of the pathogens of interest. Results: 62 observational studies in 68 publications met our inclusion criteria. Studies reported results for Staphylococcus aureus (n=61), Escherichia coli (n=9), Pseudomonas aeruginosa (n=2), Enterobacterales (n=1), Enterococcus faecium (n=1) and Klebsiella pneumoniae (n=1) and were conducted in the USA (n=48), Israel (n=6), New Zealand (n=4), Australia (n=3) and Brazil (n=1). US studies most often examined Black and Hispanic minority groups and regularly reported a higher risk of these pathogens in Black persons and mixed results for Hispanic persons. Ethnic minority groups were often reported to be at a higher risk in other countries. Conclusions: Sufficient evidence was identified to justify systematic reviews and meta-analyses evaluating the relationship between race, ethnicity and community-acquired S. aureus and E. coli, although data were rare for other pathogens. We recommend that future studies clarify whether race and ethnicity data are self-reported, collect race and ethnicity data in conjunction with the social determinants of health and make a concerted effort to include non-English speakers and Indigenous populations from the Americas, when possible.
- Open Access
- 7 August 2025
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 5 (1) , e172
Race and ethnicity and the risk of community-acquired third-generation cephalosporin-resistant uropathogens: a systematic review and meta-analysis
Objective: The objective of this systematic review and meta-analysis (SRMA) was to synthesize literature on the differences in risk of community-acquired third-generation cephalosporin resistant (3GC-R) uropathogens across racial and ethnic groups. Methods: This SRMA builds on a completed scoping review of the association between race, ethnicity, and risk of colonization or community-acquired infection with ESKAPE pathogens. A literature search was conducted for the earlier scoping review in January 2022 and updated in March 2024. Following PRISMA guidelines, titles and abstracts were screened before advancing to full-text review and data extraction. A customized extraction form in Covidence captured relevant information from each study. For this SRMA, studies identified in the scoping review that reported case counts or effect measures related to colonization or community-acquired infection with 3GC-R uropathogens across distinct identities were included. Separate random effects meta-analyses assessed differences in risk of 3GC-R uropathogens between each minority racial/ethnic group and White/Caucasian persons. Results: Five studies comprising 13,527 subjects were included in the SRMA, among which there was generally a higher risk of 3GC-R uropathogens among Hispanic/Latinx and Asian persons compared to White persons. Only the meta-analysis of Hispanic/Latinx versus White/Caucasian persons yielded a statistically significant pooled risk ratio; specifically, Hispanic/Latinx persons had a 27% higher risk of harboring 3GC-R uropathogens (95% CI: 1.04, 1.55). Conclusions: As antibiotic resistance rises in community settings, our findings support the need to understand the structural issues that underpin differential risk of 3GC-R uropathogens across race and ethnicity.
- 7 August 2025
- Published by Cambridge University Press (CUP) in Antimicrobial Stewardship & Healthcare Epidemiology
- Vol. 5 (1) , e172
Open AccessRace and ethnicity and the risk of community-acquired third-generation cephalosporin-resistant uropathogens: a systematic review and meta-analysis
Objective: The objective of this systematic review and meta-analysis (SRMA) was to synthesize literature on the differences in risk of community-acquired third-generation cephalosporin resistant (3GC-R) uropathogens across racial and ethnic groups. Methods: This SRMA builds on a completed scoping review of the association between race, ethnicity, and risk of colonization or community-acquired infection with ESKAPE pathogens. A literature search was conducted for the earlier scoping review in January 2022 and updated in March 2024. Following PRISMA guidelines, titles and abstracts were screened before advancing to full-text review and data extraction. A customized extraction form in Covidence captured relevant information from each study. For this SRMA, studies identified in the scoping review that reported case counts or effect measures related to colonization or community-acquired infection with 3GC-R uropathogens across distinct identities were included. Separate random effects meta-analyses assessed differences in risk of 3GC-R uropathogens between each minority racial/ethnic group and White/Caucasian persons. Results: Five studies comprising 13,527 subjects were included in the SRMA, among which there was generally a higher risk of 3GC-R uropathogens among Hispanic/Latinx and Asian persons compared to White persons. Only the meta-analysis of Hispanic/Latinx versus White/Caucasian persons yielded a statistically significant pooled risk ratio; specifically, Hispanic/Latinx persons had a 27% higher risk of harboring 3GC-R uropathogens (95% CI: 1.04, 1.55). Conclusions: As antibiotic resistance rises in community settings, our findings support the need to understand the structural issues that underpin differential risk of 3GC-R uropathogens across race and ethnicity.
- Open Access
- 4 August 2025
- Published by Taylor & Francis in Gut Microbes
- Vol. 17 (1) , 2541029
Role of the gut microbiome in frequent gut colonization with extended-spectrum β lactamase-producing Enterobacterales among Peruvian children
Gut colonization with extended-spectrum beta lactamase-producing Enterobacterales (ESBL-E) is increasingly common among children in low- and middle-income countries. Some children nevertheless remain never or rarely colonized during early life. Understanding how this protection is conferred could be helpful for designing future interventions to protect children's health. Here, we investigated whether differences in gut microbiome development could underlie differential susceptibility to ESBL-E gut colonization over time among children in peri-urban Lima. Weekly stool and daily surveys were collected from 345 children < 3 years old during a 2016-19 study of enteric infections. A subset of children (n = 12) was rarely gut-colonized with ESBL-E from 1-16 months of age. We performed short-read metagenomic sequencing of stool collected at 3, 6, 7, 9, 12, and 16 months from these children and a random subset of 42 frequently colonized children, and characterized differences in their exposures and gut microbiomes. No differences in gut taxa or functional pathways were identified over time, though children harbored differentially abundant taxa, more unique E. coli strains, and a higher abundance of blaCTX-M gene copies at ESBL-E-positive versus negative timepoints. Differing patterns of ESBL-E colonization over time among children in peri-urban Lima do not appear to be related to differences in gut microbiome development.
- 4 August 2025
- Published by Taylor & Francis in Gut Microbes
- Vol. 17 (1) , 2541029
Open AccessRole of the gut microbiome in frequent gut colonization with extended-spectrum β lactamase-producing Enterobacterales among Peruvian children
Gut colonization with extended-spectrum beta lactamase-producing Enterobacterales (ESBL-E) is increasingly common among children in low- and middle-income countries. Some children nevertheless remain never or rarely colonized during early life. Understanding how this protection is conferred could be helpful for designing future interventions to protect children's health. Here, we investigated whether differences in gut microbiome development could underlie differential susceptibility to ESBL-E gut colonization over time among children in peri-urban Lima. Weekly stool and daily surveys were collected from 345 children < 3 years old during a 2016-19 study of enteric infections. A subset of children (n = 12) was rarely gut-colonized with ESBL-E from 1-16 months of age. We performed short-read metagenomic sequencing of stool collected at 3, 6, 7, 9, 12, and 16 months from these children and a random subset of 42 frequently colonized children, and characterized differences in their exposures and gut microbiomes. No differences in gut taxa or functional pathways were identified over time, though children harbored differentially abundant taxa, more unique E. coli strains, and a higher abundance of blaCTX-M gene copies at ESBL-E-positive versus negative timepoints. Differing patterns of ESBL-E colonization over time among children in peri-urban Lima do not appear to be related to differences in gut microbiome development.
- Open Access
- 20 March 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-10
Neighborhood-level income and MRSA infection risk in the USA: systematic review and meta-analysis
The impact of neighborhood-level income on community-associated methicillin-resistant S. aureus (CA-MRSA) risk remains poorly understood, despite established associations between MRSA risk and the social determinants of health. There are conflicting findings in the existing literature and no known systematic reviews based in the U.S. Our objective was to conduct a systematic review and meta-analysis of the association between neighborhood-level income and CA-MRSA in the U.S. We searched MEDLINE (Ovid), MEDLINE Epub Ahead of Print, In-Process, In-Data-Review & Other Non-Indexed Citations, and Daily (Ovid), Global Health (Ovid), Embase (Elsevier), Cochrane Database of Systematic Reviews (Wiley), Cochrane Central Register of Controlled Trials (Wiley), and Web of Science Core Collection from 2017 to 10 January 2021. An updated search was completed in November 2023. Eligible studies reported stratified CA-MRSA case counts and/or effect measures by neighborhood income level, reported as a categorical or continuous variable. Relevant data were extracted using Covidence following the PRISMA guidelines. A random-effects model meta-analysis was used to estimate the pooled effect measure. Three study design-specific risk of bias assessments and a quality assessment were applied using the modified Newcastle-Ottawa Quality Assessment Scale and GRADE approach, respectively. Six publications met eligibility criteria. Five found that living in a low-income neighborhood was associated with increased CA-MRSA risk. Among the four studies eligible for the meta-analysis, the pooled odds ratio for CA-MRSA infection among low vs. high-income neighborhoods (reference group) was 1.28 (95% CI: 1.13, 1.46), with statistical heterogeneity (I2 73%). Limiting to low risk of bias studies (n = 3), there was no significant relationship between low income and CA-MRSA infection (OR: 1.13, 95% CI: 0.96, 1.33) with heterogeneity of 0%. Evidence supports an association between lower neighborhood income and higher CA-MRSA infection risk, albeit with considerable heterogeneity. Future studies should consider evaluating neighborhood-level income as a continuous variable, and at the block-group level to avoid exposure misclassification. Furthermore, researchers should consider adjusting for covariates that could allow for a causal interpretation of the relationship between low neighborhood-level income and CA-MRSA risk.
- 20 March 2025
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-10
Open AccessNeighborhood-level income and MRSA infection risk in the USA: systematic review and meta-analysis
The impact of neighborhood-level income on community-associated methicillin-resistant S. aureus (CA-MRSA) risk remains poorly understood, despite established associations between MRSA risk and the social determinants of health. There are conflicting findings in the existing literature and no known systematic reviews based in the U.S. Our objective was to conduct a systematic review and meta-analysis of the association between neighborhood-level income and CA-MRSA in the U.S. We searched MEDLINE (Ovid), MEDLINE Epub Ahead of Print, In-Process, In-Data-Review & Other Non-Indexed Citations, and Daily (Ovid), Global Health (Ovid), Embase (Elsevier), Cochrane Database of Systematic Reviews (Wiley), Cochrane Central Register of Controlled Trials (Wiley), and Web of Science Core Collection from 2017 to 10 January 2021. An updated search was completed in November 2023. Eligible studies reported stratified CA-MRSA case counts and/or effect measures by neighborhood income level, reported as a categorical or continuous variable. Relevant data were extracted using Covidence following the PRISMA guidelines. A random-effects model meta-analysis was used to estimate the pooled effect measure. Three study design-specific risk of bias assessments and a quality assessment were applied using the modified Newcastle-Ottawa Quality Assessment Scale and GRADE approach, respectively. Six publications met eligibility criteria. Five found that living in a low-income neighborhood was associated with increased CA-MRSA risk. Among the four studies eligible for the meta-analysis, the pooled odds ratio for CA-MRSA infection among low vs. high-income neighborhoods (reference group) was 1.28 (95% CI: 1.13, 1.46), with statistical heterogeneity (I2 73%). Limiting to low risk of bias studies (n = 3), there was no significant relationship between low income and CA-MRSA infection (OR: 1.13, 95% CI: 0.96, 1.33) with heterogeneity of 0%. Evidence supports an association between lower neighborhood income and higher CA-MRSA infection risk, albeit with considerable heterogeneity. Future studies should consider evaluating neighborhood-level income as a continuous variable, and at the block-group level to avoid exposure misclassification. Furthermore, researchers should consider adjusting for covariates that could allow for a causal interpretation of the relationship between low neighborhood-level income and CA-MRSA risk.
- Open Access
- 28 January 2025
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 59 (5) , 2339-2343
Strengthening Policy Relevance of Wastewater-Based Surveillance for Antimicrobial Resistance
- 28 January 2025
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 59 (5) , 2339-2343
Open AccessStrengthening Policy Relevance of Wastewater-Based Surveillance for Antimicrobial Resistance